The Pharmacoepidemiology of Selective Serotonin Reuptake Inhibitors for Children and Adolescents in Canada from 2005 to 2009: A Database Analysis

被引：0
|
作者：
Darren Lam
Daniel A. Gorman
Scott Patten
Tamara Pringsheim
机构：
[1] University of Calgary,Department of Clinical Neurosciences Psychiatry, and Pediatrics
[2] C4-431,Department of Psychiatry
[3] Alberta Children’s Hospital,Department of Community Health Sciences and Psychiatry
[4] University of Toronto,undefined
[5] University of Calgary,undefined
来源：
Pediatric Drugs | 2013年 / 15卷
关键词：
Major Depressive Disorder; Fluoxetine; Paroxetine; Escitalopram; Canadian Youth;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：319 / 327
页数：8
相关论文
共 50 条
  • [21] Juvenile depression treatment with antidepressants from the selective serotonin reuptake inhibitors group
    Suleymanov, Ramil F.
    Gorenkov, Roman V.
    Chernus, Natalya P.
    Orlov, Sergey A.
    Kalinina, Irina F.
    BANGLADESH JOURNAL OF MEDICAL SCIENCE, 2019, 18 (03): : 615 - 623
  • [22] The Effectiveness of Selective Serotonin Reuptake Inhibitors for Treatment of Obsessive-Compulsive Disorder in Adolescents and Children: A Systematic Review and Meta-Analysis
    Kotapati, Vijaya Padma
    Khan, Ali M.
    Dar, Sara
    Begum, Guishan
    Bachu, Ramya
    Adnan, Mahwish
    Zubair, Aarij
    Ahmed, Rizwan A.
    FRONTIERS IN PSYCHIATRY, 2019, 10
  • [23] Forum: the use of selective serotonin reuptake inhibitors in depressed children and adolescents: commentary on the meta-analysis by Hetrick et al.
    Goodyer, Ian M.
    Wilkinson, Paul
    Dubicka, Bernadka
    Kelvin, Raphael
    CURRENT OPINION IN PSYCHIATRY, 2010, 23 (01) : 58 - 61
  • [24] Drug-Drug Interactions of Selective Serotonin Reuptake Inhibitors: A Pharmacovigilance Study on Real-World Evidence from the EudraVigilance Database
    Dobrea, Carmen Maximiliana
    Frum, Adina
    Butuca, Anca
    Morgovan, Claudiu
    Stoicescu, Laurentiu
    Chis, Adriana Aurelia
    Arseniu, Anca Maria
    Rus, Luca Liviu
    Gligor, Felicia Gabriela
    Vonica-Tincu, Andreea Loredana
    PHARMACEUTICALS, 2024, 17 (10)
  • [25] Making a Case to Continue Considering Treatment with Selective Serotonin Reuptake Inhibitors for Children with Autism Spectrum Disorders
    Wendy Froehlich
    Current Psychiatry Reports, 2011, 13
  • [26] Results of a Retrospective Claims Database Analysis of Differences in Antidepressant Treatment Persistence Associated With Escitalopram and Other Selective Serotonin Reuptake Inhibitors in the United States
    Esposito, Dominick
    Wahl, Peter
    Daniel, Gregory
    Stoto, Michael A.
    Erder, M. Haim
    Croghan, Thomas W.
    CLINICAL THERAPEUTICS, 2009, 31 (03) : 644 - 656
  • [27] Selective serotonin reuptake inhibitors and suicidality in children and young adults: analyses of pharmacovigilance databases
    Dubrall, Diana
    Fekete, Stefanie
    Leitzen, Sarah
    Paschke, Lena Marie
    Romanos, Marcel
    Schmid, Matthias
    Gerlach, Manfred
    Sachs, Bernhardt
    BMC PHARMACOLOGY & TOXICOLOGY, 2023, 24 (01)
  • [28] Reproductive Toxicity Induced by Serotonin-Norepinephrine Reuptake Inhibitors: A Pharmacovigilance Analysis From 2004 to 2023 Based on the FAERS Database
    Xi, Yujia
    Bao, Zhuocheng
    Guo, Qiang
    Wang, Jingqi
    Jing, Zhinan
    Di, Jingkai
    Yang, Ke
    CNS NEUROSCIENCE & THERAPEUTICS, 2024, 30 (12)
  • [29] Early Selective Serotonin Reuptake Inhibitors for Recovery after Stroke: A Meta-Analysis and Trial Sequential Analysis
    Gu, Si-Chun
    Wang, Chang-De
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2018, 27 (05) : 1178 - 1189
  • [30] Hypertension associated with serotonin reuptake inhibitors: A new analysis in the WHO pharmacovigilance database and examination of dose-dependency
    Chretien, Basile
    Rabiaza, Andry
    Kazuki, Nishida
    Fedrizzi, Sophie
    Sassier, Marion
    Dolladille, Charles
    Alexandre, Joachim
    Humbert, Xavier
    PLOS ONE, 2025, 20 (03):
12345